Stephen T. Lundy Net Worth & Insider Trades
Stephen T. Lundy - CEO and President, Aspenbio Pharma, Inc
What is Stephen T. Lundy's Net Worth?
The current estimated net worth of Aspenbio Pharma, Inc's CEO and President, Stephen T. Lundy, is estimated to be about $0 . Stephen T. Lundy owns about 4,000 units of Aspenbio Pharma, Inc common stock. In the last 2 years at Aspenbio Pharma, Inc, Stephen T. Lundy has sold an estimated value of $0 worth.
What is Stephen T. Lundy's Past Insider Trading?
Stephen T. Lundy's largest purchase order was 4,000 units , worth over $7.72K on July 2, 2012. In total, Stephen T. Lundy has made about 7 transactions over 2 years of their time at Aspenbio Pharma, Inc. Stephen T. Lundy usually trades in May and July, with the busiest year in 2012.
Stephen T Lundy
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Stephen T. Lundy's' Mailing Address?
- Mailing address is C/o Venaxis, Inc. 1585 S. Perry Street Castle Rock CO 80104 CO
What are Aspenbio Pharma, Inc's Past Insider Trades?
Aspenbio Pharma, Inc's most recent insider trade came on December 2, 2016 by Barry Honig who bought 29,815 units worth $150.26K . In the last 9 years, insiders at Aspenbio Pharma, Inc have sold an estimated value of $682.38K and bought an estimated value of $569.99K worth of shares. Insider trading is most common in January, with the busiest year in 2012. The most active traders at the company are Douglas I Hepler, Director, Jeffrey McGonegal, Chief Financial Officer, and Gail Schoettler, Director .
Bioptix, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||